HistoIndex and Global Liver Experts Advance Stain-free AI Quantification of Hepatocyte Ballooning as a Reproducible Approach and Potential Endpoint for NASH Clinical Trials
An invisible liver disease balloons into view
Non-alcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH)_Liver Disease Models_(测式环境)Kunming Biomed International (KBI)
Liver Pathology Flashcards | Quizlet
Pathology of alcoholic liver disease, can it be differentiated from nonalcoholic steatohepatitis?
Hepatocellular ballooning in NASH. | Semantic Scholar
Non-Alcoholic Fatty Liver Disease - Gastroenterology & Endoscopy News
Macro steatosis, micro steatosis and ballooning in liver of insulin resistant baboons.
Liver Pathology: Steatohepatitis | Liver Fellow Network
High frequency and long persistency of ballooning hepatocyte were associated with glucose intolerance in patients with severe obesity | Scientific Reports
Clinical implications of hepatic progenitor cell activation in non-alcoholic fatty liver disease
Frontiers | Liver Fibrosis in Non-alcoholic Fatty Liver Disease: From Liver Biopsy to Non-invasive Biomarkers in Diagnosis and Treatment
File:Ballooning degeneration high mag.jpg - Wikimedia Commons
PATHOLOGY OF NAFLD
Human translatability of the GAN diet-induced obese mouse model of non-alcoholic steatohepatitis | BMC Gastroenterology | Full Text
Heather L Stevenson, MD, PhD on Twitter: "A common question asked from our residents and fellows, “how do you tell the difference between true ballooning degeneration and steatosis?” #liverpath #meded @ALBoothMD @DrMariMore @
MANAGEMENT OF ENDOCRINE DISEASE: Non-alcoholic fatty liver disease: a multidisciplinary approach towards a cardiometabolic liver disease in: European Journal of Endocrinology Volume 183 Issue 3 (2020)
Fatty Liver Disease: Alcoholic and Nonalcoholic | Abdominal Key
Effect of Metformin on Ballooning Degeneration in Nonalcoholic Steatohepatitis (NASH): When to Use Metformin in Nonalcoholic Fatty Liver Disease (NAFLD) | SpringerLink
Nonalcoholic Fatty Liver Disease: A Pathological View | IntechOpen
Pathology Outlines - Nonalcoholic fatty liver disease / nonalcoholic steatohepatitis (NASH)
High-Throughput, Machine Learning–Based Quantification of Steatosis, Inflammation, Ballooning, and Fibrosis in Biopsies From Patients With Nonalcoholic Fatty Liver Disease - ScienceDirect
Non-alcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH)_Liver Disease Models_Kunming Biomed International (KBI)
Glutaminolysis-ammonia-urea Cycle Axis, Non-alcoholic Fatty Liver Disease Progression and Development of Novel Therapies
